UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 26, pp. 2518 - 2528
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Enzyme Inhibitors - adverse effects | Lung Diseases, Interstitial - etiology | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Male | Diarrhea - chemically induced | Enzyme Inhibitors - therapeutic use | Lung Diseases, Interstitial - drug therapy | Disease Progression | Vital Capacity | Indoles - adverse effects | Scleroderma, Systemic - complications | Adult | Female | Indoles - therapeutic use | Lung Diseases, Interstitial - physiopathology | Scleroderma, Systemic - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Drug therapy | Sclerosis | Tyrosine | Mycophenolic acid | Sensitivity analysis | Lung diseases | Rheumatology | Oral administration | Clinical trials | Diarrhea | Patients | Pulmonary hypertension | Pulmonary fibrosis | Computed tomography | Systemic sclerosis | Technical communication | Fibrosis | Skin | Scleroderma | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2009, Volume 68, Issue 5, pp. 620 - 628
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Diseases of the osteoarticular system | Lung Diseases, Interstitial - etiology | Evidence-Based Medicine - methods | Raynaud Disease - drug therapy | Humans | Gastrointestinal Diseases - etiology | Kidney Diseases - drug therapy | Treatment Outcome | Raynaud Disease - etiology | Lung Diseases, Interstitial - drug therapy | Gastrointestinal Diseases - drug therapy | Scleroderma, Systemic - complications | Hypertension, Pulmonary - drug therapy | Kidney Diseases - etiology | Hypertension, Pulmonary - etiology | Scleroderma, Systemic - drug therapy | Medical research | Care and treatment | Usage | Systemic scleroderma | Scleroderma (Disease) | Medicine, Experimental | Reports | Management | Evidence-based medicine | Disease | Antibiotics | Experts | Mortality | Ulcers | Quality | Committees | Rheumatism | Scleroderma | Patients | Index Medicus
Journal Article
Clinical and experimental rheumatology, ISSN 0392-856X, 2015, Volume 33, Issue 4, pp. S3 - S7
Vasculopathy | Scleroderma | Systemic sclerosis | Cytokine | Fibrosis | Growth factor | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Inflammation Mediators - immunology | Humans | Immunosuppressive Agents - therapeutic use | Scleroderma, Systemic - metabolism | Treatment Outcome | Scleroderma, Systemic - immunology | Molecular Targeted Therapy | Remission Induction | Scleroderma, Systemic - diagnosis | Animals | Signal Transduction - drug effects | Inflammation Mediators - metabolism | Immunosuppressive Agents - adverse effects | Scleroderma, Systemic - drug therapy | Index Medicus
Journal Article
Seminars in immunopathology, ISSN 1863-2297, 1/2016, Volume 38, Issue 1, pp. 87 - 95
Localized scleroderma | Biomedicine | Immunology | Serotonin | Systemic sclerosis | Soluble guanylate cyclase | Nintedanib | Internal Medicine | Interleukin-6 | Pathology | Life Sciences & Biomedicine | Science & Technology | Scleroderma, Localized - etiology | Scleroderma, Localized - metabolism | Interleukin-6 - therapeutic use | Scleroderma, Localized - drug therapy | Scleroderma, Systemic - etiology | Protein Kinase Inhibitors - therapeutic use | Humans | Scleroderma, Systemic - metabolism | Serotonin Antagonists - therapeutic use | Guanylate Cyclase - metabolism | Molecular Targeted Therapy | Scleroderma, Systemic - drug therapy | Systemic scleroderma | Mortality | Scleroderma (Disease) | Index Medicus
Journal Article
Clinical rheumatology, ISSN 0770-3198, 11/2020, Volume 39, Issue 11, pp. 3195 - 3204
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Arthritis, Psoriatic - epidemiology | Autoimmune Diseases - physiopathology | Glucocorticoids - therapeutic use | Undifferentiated Connective Tissue Diseases - epidemiology | Pandemics | Rheumatic Diseases - drug therapy | Arthritis, Psoriatic - physiopathology | Humans | Middle Aged | Coronavirus Infections - physiopathology | Male | Dermatomyositis - physiopathology | COVID-19 | Rheumatic Diseases - epidemiology | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Arthritis, Rheumatoid - drug therapy | Dermatomyositis - drug therapy | Arthritis, Psoriatic - drug therapy | Scleroderma, Systemic - physiopathology | Lupus Erythematosus, Systemic - drug therapy | Sjogren's Syndrome - epidemiology | Spondylitis, Ankylosing - epidemiology | Aged, 80 and over | Betacoronavirus | Adult | Female | Arthritis, Rheumatoid - physiopathology | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use | Autoimmune Diseases - epidemiology | Lupus Erythematosus, Systemic - epidemiology | Sjogren's Syndrome - drug therapy | Spondylitis, Ankylosing - drug therapy | Arthritis, Rheumatoid - epidemiology | Dermatomyositis - epidemiology | Sjogren's Syndrome - physiopathology | Spondylitis, Ankylosing - physiopathology | Undifferentiated Connective Tissue Diseases - physiopathology | Scleroderma, Systemic - epidemiology | Pneumonia, Viral - physiopathology | Undifferentiated Connective Tissue Diseases - drug therapy | Rheumatic Diseases - physiopathology | Italy - epidemiology | Aged | Lupus Erythematosus, Systemic - physiopathology | Scleroderma, Systemic - drug therapy | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 2013, Volume 503, Issue 7474, pp. 126 - 130
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fibrosis - drug therapy | Antibodies, Antinuclear - immunology | Scleroderma, Systemic - pathology | Skin Diseases, Genetic - drug therapy | Male | Integrins - metabolism | Mutation, Missense - genetics | Contracture - drug therapy | Plasma Cells - drug effects | T-Lymphocytes, Helper-Inducer - drug effects | Antibodies, Neutralizing - immunology | Autoimmunity - immunology | Antibodies, Neutralizing - therapeutic use | Integrins - drug effects | Transforming Growth Factor beta - antagonists & inhibitors | Dendritic Cells - drug effects | Female | Contracture - prevention & control | Microfilament Proteins - metabolism | Skin Diseases, Genetic - prevention & control | Contracture - immunology | Fibrosis - prevention & control | Microfilament Proteins - genetics | Transforming Growth Factor beta - immunology | Microfilament Proteins - chemistry | Fibrillin-1 | Skin Diseases, Genetic - immunology | Contracture - pathology | Skin Diseases, Genetic - pathology | Antibodies, Neutralizing - pharmacology | Fibrillins | Scleroderma, Systemic - immunology | Animals | Amino Acid Substitution - genetics | Mice | Fibrosis - pathology | Amino Acid Motifs - genetics | Autoimmunity - drug effects | Scleroderma, Systemic - drug therapy | Scleroderma, Systemic - prevention & control | Autoimmunity | Cell interaction | Systemic scleroderma | Scleroderma (Disease) | Research | Prevention | Complications and side effects | Fibrosis | Physiological aspects | Dosage and administration | Drug therapy | Molecular biology | Health aspects | Integrins | Flow cytometry | Cell culture | Cytokines | Rodents | Collagen | Mutation | Scleroderma | Age | Index Medicus
Journal Article
Seminars in arthritis and rheumatism, ISSN 0049-0172, 2017, Volume 46, Issue 5, pp. 625 - 631
Rheumatology | Rituximab | B cells | Scleroderma | Interstitial lung disease | Systemic sclerosis | Fibrosis | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Male | Lymphocyte Depletion | Case-Control Studies | Time Factors | Scleroderma, Systemic - complications | Adult | Female | Retrospective Studies | Immunosuppressive Agents - administration & dosage | Skin - pathology | Rituximab - adverse effects | Lung - pathology | Kaplan-Meier Estimate | Lung Diseases, Interstitial - complications | Lung Diseases, Interstitial - drug therapy | Rituximab - administration & dosage | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Lung - drug effects | Immunosuppressive Agents - adverse effects | Aged | Scleroderma, Systemic - drug therapy | Skin - drug effects | Systemic scleroderma | Comparative analysis | Lung diseases | Scleroderma (Disease) | Medical research | Medicine, Experimental | Mycophenolate mofetil | Methotrexate | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2016, Volume 387, Issue 10038, pp. 2630 - 2640
Internal Medicine | Medicine(all) | Multicenter Study | Clinical Trial, Phase II | Randomized Controlled Trial | Research Support, Non-U.S. Gov't | Journal Article | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biomarkers - metabolism | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Europe | Humans | Middle Aged | Scleroderma, Systemic - metabolism | Male | Treatment Outcome | United Kingdom | Canada | Vital Capacity | Antibodies, Monoclonal, Humanized - administration & dosage | Injections, Subcutaneous | Scleroderma, Systemic - complications | Interleukin-6 - physiology | Adult | Female | Aged | Scleroderma, Systemic - drug therapy | Medical colleges | Adults | Systemic scleroderma | Interleukins | Scleroderma (Disease) | Analysis | Cytokines | Ulcers | Biomarkers | Fibroblasts | Clinical trials | Patient safety | Skin diseases | Skin | Health risk assessment | Scleroderma | Drug therapy | Tissues | Pathogenesis | Interleukin | Evidence-based medicine | Itching | Interleukin 6 | Cost-benefit analysis | Safety | Thickening | Effectiveness | Mortality | Lung diseases | Medical treatment | Rheumatology | Patients | Studies | Systemic sclerosis | Least squares | Autoimmune diseases | Index Medicus | Abridged Index Medicus
Journal Article